Industry News
Breast Cancer May Regress When Hormone Therapy Ceases
Mar 01, 2012
As soon as women quit hormone therapy, their rates of new breast cancer decline, supporting the hypothesis that stopping hormones can lead to tumor regression, according to a report e-published in Cancer Epidemiology, Biomarkers, & Prevention. As part of the national Breast Cancer Surveillance Consortium, researchers studied 741,681 woman-years of data (with a median of 3... Read More
Repeat Breast Cancer Surgeries Reduced When Pathology Evaluations Done On-Site
Mar 01, 2012
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist. A new service at the University of Michigan Comprehensive Cancer Center cuts that number drastically by having pathologists on-site in the operating suite to assess tumors and lymph nodes immediately after they are removed... Read More
Potential Solution To Melanoma's Resistance To Vemurafenib
Mar 01, 2012
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma. Vemurafenib resistance is characterized by a diminished apoptosis (programmed cancer cell death) response... Read More
Nurses Key In Helping New Cancer Patients Overcome Fears
Mar 01, 2012
Often faced with overwhelming anxiety, patients newly diagnosed with lung cancer can find themselves in distress, and new research recommends nurses play a key role in alleviating concerns, leading to a better quality of life for patients... Read More
Breast Cancer May Regress When Hormone Therapy Ceases
Mar 01, 2012
As soon as women quit hormone therapy, their rates of new breast cancer decline, supporting the hypothesis that stopping hormones can lead to tumor regression, according to a report e-published in Cancer Epidemiology, Biomarkers, & Prevention. As part of the national Breast Cancer Surveillance Consortium, researchers studied 741,681 woman-years of data (with a median of 3... Read More
Repeat Breast Cancer Surgeries Reduced When Pathology Evaluations Done On-Site
Mar 01, 2012
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist. A new service at the University of Michigan Comprehensive Cancer Center cuts that number drastically by having pathologists on-site in the operating suite to assess tumors and lymph nodes immediately after they are removed... Read More
Melanoma Passes From Mother To Unborn
Feb 29, 2012
Malignant Melanoma is known to be highly aggressive, spreading rapidly to other parts of the body if left untreated. It's extremely rare, however, for it to be able to pass to an unborn fetus. This is what appears to have happened in the case of Briana Cox, who had malignant skin melanoma removed in 2006... Read More
Melanoma Passes From Mother To Unborn
Feb 29, 2012
Malignant Melanoma is known to be highly aggressive, spreading rapidly to other parts of the body if left untreated. It's extremely rare, however, for it to be able to pass to an unborn fetus. This is what appears to have happened in the case of Briana Cox, who had malignant skin melanoma removed in 2006... Read More
Cancer Mortality Drops In Europe
Feb 29, 2012
A new estimate, published today in the cancer journal Annals of Oncology, reveals that 717,398 men and 565,703 women (1.3 million people) in the European Union (EU) will die from cancer in 2012. Even though the actual numbers have risen, the rate (age-standardized per 100,000 population) of individuals who die from cancer is still declining... Read More
Monitoring Sickle Cell Disease - Measuring Blood Flow
Feb 29, 2012
Worldwide, over 13 million people suffer from sickle cell disease, for which few treatment options exist. Over six decades ago, scientists discovered the cause of sickle cell disease... Read More
Previous Page Next Page